Results 1 to 10 of about 15,366 (199)

A case of neurofibromatosis type 1 with neurofibromatosis type 1-related and neurofibromatosis type 1-unrelated tumors: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Neurofibromatosis type 1 is an autosomal dominantly inherited disorder caused by pathogenic variants in the neurofibromatosis type 1 gene, resulting in a predisposition to multiple tumors.
Tabea I. Hartung   +3 more
doaj   +3 more sources

Clinical Masks of Neurofibromatosis Type 1

open access: yesАрхивъ внутренней медицины, 2022
Neurofibromatosis type 1 is the most common autosomal dominant tumor syndrome. The prevalence of the disease is 1 in 3000 people. Neurofibromatosis type 1 is characterized by the gradual appearance of signs of the disease and pronounced clinical ...
R. N. Mustafin
doaj   +2 more sources

Loss of EPB41L3: a common molecular link in the tumorigenesis of neurofibromatosis types 1 and 2 [PDF]

open access: yesFrontiers in Oncology
BackgroundNeurofibromatosis type 1 (NF1) and Neurofibromatosis type 2 (NF2) are autosomal dominant disorders that originate from Schwann cells and are characterized by the development of benign and malignant tumors, respectively.
Erxing Tao   +13 more
doaj   +2 more sources

MEK inhibitors - novel targeted therapies of neurofibromatosis associated benign and malignant lesions [PDF]

open access: yesBiomarker Research, 2021
MAP/ERK kinase 1 and 2 (MEK 1/2) inhibitors (MEKi) are investigated in several trials to treat lesions that arise from pathogenic variants of the Neurofibromatosis type 1 and type 2 genes (NF1, NF2).
Anja Harder
doaj   +3 more sources

Evaluation of Neurofibromatosis Gene Expression in Non-Hereditary Breast Cancer

open access: yesNovelty in Biomedicine, 2023
Background: Breast cancer is the most common cause of death in women. Studies have shown that changes in neurofibromatosis gene expression can cause breast cancer.
Mahsa Kavousi   +3 more
doaj   +3 more sources

Neurofibromatosis type 1: a single center's experience in Korea [PDF]

open access: yesKorean Journal of Pediatrics, 2014
PurposeNeurofibromatosis 1 (NF1) is an autosomal dominant condition caused by an NF1 gene mutation. NF1 is also a multisystem disorder that primarily affects the skin and nervous system.
Min Jeong Kim, Chong Kun Cheon
doaj   +1 more source

NF1 Gene and Neurofibromatosis 1 [PDF]

open access: yesAmerican Journal of Epidemiology, 2000
Neurofibromatosis 1 (NF1), also known as von Recklinghausen disease, is an autosomal dominant condition caused by mutations of the NF1 gene, which is located at chromosome 17q11.2. NF1 is believed to be completely penetrant, but substantial variability in expression of features occurs. Diagnosis of NF1 is based on established clinical criteria.
S A, Rasmussen, J M, Friedman
openaire   +2 more sources

A Conserved Circadian Function for the Neurofibromatosis 1 Gene [PDF]

open access: yesCell Reports, 2018
Loss of the Neurofibromatosis 1 (Nf1) protein, neurofibromin, in Drosophila disrupts circadian rhythms of locomotor activity without impairing central clock function, suggesting effects downstream of the clock. However, the relevant cellular mechanisms are not known.
Bai, Lei   +10 more
openaire   +4 more sources

Co-occurrence of neurofibromatosis type 1 and pseudoachondroplasia – a first case report

open access: yesBMC Pediatrics, 2023
Background Neurofibromatosis type 1 and pseudoachondroplasia are both rare autosomal dominant disorders, caused by pathogenic mutations in NF1 and COMP genes, respectively.
Sára Pálla   +11 more
doaj   +1 more source

Neuroibromatosis tipo l: relación genotipo-fenotipo

open access: yesActa Neurológica Colombiana, 2020
INTRODUCCIÓN: La neurofibromatosis (enfermedad de von Recklinghausen) es una enfermedad autosómica dominante que presenta principalmente manifestaciones cutáneas y neurológicas.
Mariana Teresa Gómez-López   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy